(Q38940907)

7 September 2017

title

A multifunctional bispecific antibody protects against Pseudomonas aeruginosa (English)

1 reference

7 September 2017

main subject

Pseudomonas aeruginosa

0 references

1 reference

Antonio DiGiandomenico

1

1 reference

7 September 2017

Ashley E Keller

2

1 reference

7 September 2017

Cuihua Gao

3

1 reference

7 September 2017

Godfrey J Rainey

4

1 reference

7 September 2017

Paul Warrener

5

1 reference

7 September 2017

Mareia M Camara

6

1 reference

7 September 2017

Jessica Bonnell

7

1 reference

7 September 2017

Ryan Fleming

8

1 reference

7 September 2017

Binyam Bezabeh

9

1 reference

7 September 2017

Nazzareno Dimasi

10

1 reference

7 September 2017

Bret R Sellman

11

1 reference

7 September 2017

Jamese Hilliard

12

1 reference

7 September 2017

Caitlin M Guenther

13

1 reference

7 September 2017

Vivekananda Datta

14

1 reference

7 September 2017

Wei Zhao

15

1 reference

7 September 2017

Changshou Gao

16

1 reference

7 September 2017

Xiang-Qing Yu

17

1 reference

7 September 2017

JoAnn A Suzich

18

1 reference

7 September 2017

C Kendall Stover

19

1 reference

7 September 2017

language of work or name

English

0 references

publication date

1 November 2014

1 reference

Science Translational Medicine

7 September 2017

published in

1 reference

7 September 2017

volume

6

1 reference

7 September 2017

issue

262

1 reference

7 September 2017

page(s)

262ra155

1 reference

Serum therapy revisited: animal models of infection and development of passive antibody therapy

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

Return to the Past: The Case for Antibody-Based Therapies in Infectious Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

Clinical relevance of the ESKAPE pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

Identification of broadly protective human antibodies to Pseudomonas aeruginosa exopolysaccharide Psl by phenotypic screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

Identification of psl, a locus encoding a potential exopolysaccharide that is essential for Pseudomonas aeruginosa PAO1 biofilm formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

Pseudomonas aeruginosa Psl polysaccharide reduces neutrophil phagocytosis and the oxidative response by limiting complement-mediated opsonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

A novel anti-PcrV antibody providing enhanced protection against Pseudomonas aeruginosa in multiple animal infection models

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

A signaling network reciprocally regulates genes associated with acute infection and chronic persistence in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

Key two-component regulatory systems that control biofilm formation in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

Multiple sensors control reciprocal expression of Pseudomonas aeruginosa regulatory RNA and virulence genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

Design and production of novel tetravalent bispecific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

Dual targeting strategies with bispecific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

Antibody-based candidate therapeutics against HIV-1: implications for virus eradication and vaccine design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

A novel multivalent, single-domain antibody targeting TcdA and TcdB prevents fulminant Clostridium difficile infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

A single VHH-based toxin-neutralizing agent and an effector antibody protect mice against challenge with Shiga toxins 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

Association between cytotoxic and invasive Pseudomonas aeruginosa and clinical outcomes in bacterial keratitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

Prevalence of type III secretion protein exoenzymes and antimicrobial susceptibility patterns from bloodstream isolates of patients with Pseudomonas aeruginosa bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

The type III secretion system of Pseudomonas aeruginosa: infection by injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

PscF is a major component of the Pseudomonas aeruginosa type III secretion needle

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

Cross talk between type III secretion and flagellar assembly systems in Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

Vaccination against Pseudomonas aeruginosa pneumonia in immunocompromised mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

Genotyping of Pseudomonas aeruginosa strains isolated from burn patients by RAPD-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

Pseudomonas aeruginosa forms biofilms in acute infection independent of cell-to-cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

Analysis of Pseudomonas aeruginosa conditional psl variants reveals roles for the psl polysaccharide in adhesion and maintaining biofilm structure postattachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

Role of polysaccharides in Pseudomonas aeruginosa biofilm development

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

Antibiotic interactions that select against resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

Intranasal immunization with heterologously expressed polysaccharide protects against multiple Pseudomonas aeruginosa infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

Calculation of a new Meeh constant and experimental determination of burn size

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

Hybrid hybridomas and their use in immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

Thermal injury induces impaired function in polymorphonuclear neutrophil granulocytes and reduced control of burn wound infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009655

10.1126/SCITRANSLMED.3009655

21 January 2018

Identifiers

DOI

1 reference

7 September 2017

1 reference